alexion inc

    Country:  United Kingdom

    Business Type: Trading Company

  • Mr.kelly cole
    Tel: +44-7031859792

  • Mobile:
  • Tel:+44-7031859792
  • Fax:+44-
  • Province/state:
  • City:Ealing
  • Street:Ealing,W5
  • MaxCard:
    Products Categories
    About us

  • Welcome To Our Site!

  • Alexion is a global biopharmaceutical company that combines groundbreaking science with a steadfast commitment to meeting the needs of patients living with severe, life-threatening and often ultra-rare diseases. Alexion scientists are among the first in the world to unlock the therapeutic potential of inhibiting terminal complement, a group of proteins that play an important role in the body's immune response and can destroy healthy tissue in certain patients.

    Alexion discovered and developed Soliris? (eculizumab), a first-in-class terminal complement inhibitor. Today, Soliris is approved in more than 40 countries as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH), and in the United States and European Union as a treatment for patients with atypical hemolytic uremic syndrome (aHUS). Soliris is not indica  Click for details>>

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog

hot product 12001-29-5 105618-26-6 55133-89-6 15520-11-3 552858-79-4